Memory-like (ML) NK cells can ignore some inhibitory receptors, such as KIR, and exhibit higher expression of the activating receptors, such as NKG2D, NKp46, and DNAM-1, suggesting their potential effectiveness in recognizing additional tumor types (26). The gene discussed is CD226; the disease is neoplasm.